REDWOOD CITY, Calif.,
Oct. 24, 2016 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device company
that is providing innovative evidence-based solutions for the
treatment of chronic pain, today announced that it will release
financial results for the third quarter of 2016 after market close
on Monday, November 7, 2016. Company
management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Monday, November 7, 2016.
Investors interested in listening to the conference call may do
so by dialing (877) 201-0168 for U.S. callers, or (647) 788-4901
for international callers (Conference ID: 92481738), or from the
webcast on the "Investors" section of the Company's website at
www.nevro.com/investors. Following the call, a replay will be
available on the Investor Events and Presentations webpage of the
Company's website.
About Nevro
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on providing innovative products that improve the quality of life
of patients suffering from debilitating chronic pain. Nevro has
developed and commercialized the Senza spinal cord stimulation
(SCS) system, an evidence-based neuromodulation platform for the
treatment of chronic pain. The Senza system is the only SCS system
that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro
and the Nevro logo are trademarks of Nevro.
Investor Relations Contact:
Nevro Investor
Relations
Katherine Bock
(650) 433-3247
ir@nevro.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nevro-to-report-operating-results-for-the-third-quarter-2016-300349948.html
SOURCE Nevro Corp.